Cargando…

Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers

Unlike in normal epithelium, dysregulated overactivation of various proteases have been reported in cancers. Degradation of pericancerous extracellular matrix leading to cancer cell invasion by matrix metalloproteases is well known evidence. On the other hand, several cell-surface proteases, includi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukai, Shoichiro, Yamasaki, Koji, Fujii, Masato, Nagai, Takahiro, Terada, Naoki, Kataoka, Hiroaki, Kamoto, Toshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215454/ https://www.ncbi.nlm.nih.gov/pubmed/32290402 http://dx.doi.org/10.3390/ijms21082663

Ejemplares similares

Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis
por: Yamasaki, Koji, et al.
Publicado: (2018)

Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation
por: Yamasaki, Koji, et al.
Publicado: (2018)

Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis
por: Nakahara, Kozue, et al.
Publicado: (2019)

Myopericytoma in urinary bladder: a case report
por: Nagai, Takahiro, et al.
Publicado: (2017)

Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer
por: Kamibeppu, Toyoharu, et al.
Publicado: (2018)

A case of von Hippel–Lindau disease with renal cell carcinoma treated by partial nephrectomy with pre- and post-surgical axitinib therapy
por: Akioka, Takahiro, et al.
Publicado: (2021)

Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis
por: Mukai, Shoichiro, et al.
Publicado: (2014)

Urinary bladder pyogenic granuloma: a case report
por: Mukai, Shoichiro, et al.
Publicado: (2012)

En bloc removal of a large leiomyosarcoma arising from the inferior vena cava using retroperitoneal laparoscopic dissection of posterior vessels followed by cavectomy in a thoracoabdominal approach
por: Kida, Kazutaka, et al.
Publicado: (2019)

Identification of the α2 chain of interleukin‐13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient‐derived xenograft models
por: Nagai, Takahiro, et al.
Publicado: (2022)

Accompanying role of hepato-biliary-pancreas surgeon in urological surgery
por: Nanashima, Atsushi, et al.
Publicado: (2017)

Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma
por: Schneider, Marc A., et al.
Publicado: (2022)

c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
por: Szabo, Roman, et al.
Publicado: (2011)

Interaction of Protein C Inhibitor with the Type II Transmembrane Serine Protease Enteropeptidase
por: Prohaska, Thomas A., et al.
Publicado: (2012)

Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer
por: Luostari, Kaisa, et al.
Publicado: (2014)

Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease
por: Zhang, Ce, et al.
Publicado: (2020)

Evolutionary history of type II transmembrane serine proteases involved in viral priming
por: Forni, Diego, et al.
Publicado: (2022)

Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2)
por: Fan, Lei, et al.
Publicado: (2021)

Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19
por: Posadas-Sánchez, Rosalinda, et al.
Publicado: (2022)

Type II Transmembrane Serine Proteases as Modulators in Adipose Tissue Phenotype and Function
por: Wu, Qingyu, et al.
Publicado: (2023)

PER3 polymorphisms and their association with prostate cancer risk in Japanese men
por: HINOURA, TAKUJI, et al.
Publicado: (2021)

Met in Urological Cancers
por: Miyata, Yasuyoshi, et al.
Publicado: (2014)

Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2
por: Wu, Ching-Yuan, et al.
Publicado: (2020)

Docking study of transmembrane serine protease type 2 inhibitors for the treatment of COVID-19
por: Solanki, Naishadh
Publicado: (2022)

Safe Resection of Renal Cell Carcinoma with Liver Invasion Using Liver Hanging Technique Supported by Preoperative Portal Vein Embolization
por: Fujii, Masato, et al.
Publicado: (2018)

Epithelioid Angiomyolipoma with Tumor Thrombus into Inferior Vena Cava Presurgically Treated with Combination Therapy of Pembrolizumab and Axitinib: A Case Report
por: Kawasoe, Chihiro, et al.
Publicado: (2023)

Laparoscopic anterior pelvic exenteration for locoregionally advanced rectal cancer directly invading the urinary bladder: A case report of low anterior resection with en bloc cystectomy for sphincter preservation
por: Ishizaki, Hidenobu, et al.
Publicado: (2015)

Surgical intervention for renal cell carcinoma with inferior vena cava extension combined with laparoscopic procedure
por: Kamimura, Toshio, et al.
Publicado: (2017)

The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes
por: Ferrara, Francesca, et al.
Publicado: (2013)

Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A
por: Wang, Hongge, et al.
Publicado: (2019)

rs12329760 Polymorphism in Transmembrane Serine Protease 2 Gene and Risk of Coronavirus Disease 2019 Mortality
por: Beheshti Shirazi, Saeedeh Sadat, et al.
Publicado: (2022)

Impacts of transmembrane serine protease 4 expression on susceptibility to severe acute respiratory syndrome coronavirus 2
por: Tan, Qi, et al.
Publicado: (2023)

TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer
por: Kim, Semi
Publicado: (2023)

TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer
por: Gaweł‐Bęben, Katarzyna, et al.
Publicado: (2017)

The Transmembrane Serine Protease HAT-like 4 Is Important for Epidermal Barrier Function to Prevent Body Fluid Loss
por: Zhang, Zhiwei, et al.
Publicado: (2017)

Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies
por: Elbadwi, Fatima A., et al.
Publicado: (2021)

Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells
por: Wang, Jun-Ying, et al.
Publicado: (2018)

Computational Analysis of Missense Variants in the Human Transmembrane Protease Serine 2 (TMPRSS2) and SARS-CoV-2
por: Saih, Asmae, et al.
Publicado: (2021)

Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity
por: Villapalos-García, Gonzalo, et al.
Publicado: (2022)

Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
por: Arefin, Samsul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qvf25lj7lb7glbhs8ha5c1s6a6